week 3 tirzepatide 4 maintenance with @morphwellnessmd is in the books!, #morphwellnessmd #morphyourself #morphmd #morphhealthandwellness , #WeightLossJourney #Tirzepatide #gethealthywithme Week 3 of Mounjaro (Tirzepatide)

A previous study indicated that treatment with the GLP-1 agonist liraglutide (subcutaneously at a dose gradually titrated from 0.6 to 3 mg) in bipolar and mood disorder depression patients could result in an improvement in cognitive function and an alleviation of depressive pathological symptoms ( Considering this evidence, increasing neurogenesis in the brain through the GLP-1 pathway may provide a novel approach for improving depressive-like behavior in patients with depression

If you experience vomiting, or are unable to go about your normal activities, please call the doctors office

Cheetham TD, Holly JM, Clayton K, Cwyfan-Hughes S, Dunger DB

When used in combination with a healthy, low-calorie eating plan and regular physical activity, many people achieve excellent results with GLP-1 medications

Keeping detailed records of your first-use date helps prevent accidental administration of degraded medication beyond the stable window

Understanding proper peptide injection technique becomes especially important when you are working at these small volumes, because air bubbles that are negligible in larger draws can represent a meaningful percentage of a 5-unit dose